Advertisement
Canada markets open in 6 hours 35 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7312
    +0.0014 (+0.19%)
     

  • CRUDE OIL

    82.88
    +0.07 (+0.08%)
     

  • Bitcoin CAD

    87,898.81
    -3,444.80 (-3.77%)
     

  • CMC Crypto 200

    1,390.44
    +7.87 (+0.57%)
     

  • GOLD FUTURES

    2,332.30
    -6.10 (-0.26%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,430.00
    -234.50 (-1.33%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6814
    -0.0005 (-0.07%)
     

Is Johnson & Johnson Stock Worth Buying on the Dip?

Jim Halley, The Motley Fool
·4 min read
Is Johnson & Johnson Stock Worth Buying on the Dip?

The news hasn't been great lately for healthcare giant Johnson & Johnson (NYSE: JNJ). On Jan. 24, the company reported fourth-quarter revenue of $23.7 billion, down 4.4% year over year, and earnings per share (EPS) of $1.33, down 24.9% over the previous year's quarter. Then, on Jan. 30, the Third Circuit Court of Appeals rejected the company's use of Chapter 11 bankruptcy in a shell company known as LTL Management, to avoid lawsuits over whether its talc products caused cancer.

Continue reading